{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:35:56Z","timestamp":1787960156288,"version":"build-2784847793"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T00:00:00Z","timestamp":1535587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Improving early detection of colorectal cancer (CRC) is a key public health priority as adenomas and stage I cancer can be treated with minimally invasive procedures. Population screening strategies based on detection of occult blood in the feces have contributed to enhance detection rates of localized disease, but new approaches based on genetic analyses able to increase specificity and sensitivity could provide additional advantages compared to current screening methodologies. Recently, circulating cell-free DNA (cfDNA) has received much attention as a cancer biomarker for its ability to monitor the progression of advanced disease, predict tumor recurrence and reflect the complex genetic heterogeneity of cancers. Here, we tested whether analysis of cfDNA is a viable tool to enhance detection of colon adenomas. To address this, we assessed a cohort of patients with adenomas and healthy controls using droplet digital PCR (ddPCR) and mutation-specific assays targeted to trunk mutations. Additionally, we performed multiregional, targeted next-generation sequencing (NGS) of adenomas and unmasked extensive heterogeneity, affecting known drivers such as\n                    <jats:italic>AP<\/jats:italic>\n                    C,\n                    <jats:italic>KRAS<\/jats:italic>\n                    and mismatch repair (MMR) genes. However, tumor-related mutations were undetectable in patients\u2019 plasma. Finally, we employed a preclinical mouse model of\n                    <jats:italic>Apc<\/jats:italic>\n                    -driven intestinal adenomas and confirmed the inability to identify tumor-related alterations via cfDNA, despite the enhanced disease burden displayed by this experimental cancer model. Therefore, we conclude that benign colon lesions display extensive genetic heterogeneity, that they are not prone to release DNA into the circulation and are unlikely to be reliably detected with liquid biopsies, at least with the current technologies.\n                  <\/jats:p>","DOI":"10.1038\/s41419-018-0934-x","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T09:29:50Z","timestamp":1535621390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity"],"prefix":"10.1038","volume":"9","author":[{"given":"Ni Ni Moe","family":"Myint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay M.","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fernandez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panchali","family":"Sarmah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Tarpey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif Sattar","family":"Al-Aqbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9329-9344","authenticated-orcid":false,"given":"Ricky","family":"Trigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne M.","family":"Howells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0418-580X","authenticated-orcid":false,"given":"David S.","family":"Guttery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baljit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard J.","family":"Pringle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ultan","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqui A.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rufini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,30]]},"reference":[{"key":"934_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3322\/caac.21395","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L. et al. Colorectal cancer statistics, 2017. CA Cancer J. Clin. 67, 177\u2013193 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"934_CR2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759\u2013767 (1990).","journal-title":"Cell"},{"key":"934_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1365-2559.2006.02549.x","volume":"50","author":"JR Jass","year":"2007","unstructured":"Jass, J. R. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50, 113\u2013130 (2007).","journal-title":"Histopathology"},{"key":"934_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ng.3214","volume":"47","author":"A Sottoriva","year":"2015","unstructured":"Sottoriva, A. et al. A Big Bang model of human colorectal tumor growth. Nat. Genet. 47, 209\u2013216 (2015).","journal-title":"Nat. Genet."},{"key":"934_CR5","doi-asserted-by":"publisher","first-page":"e1005778","DOI":"10.1371\/journal.pgen.1005778","volume":"12","author":"R Uchi","year":"2016","unstructured":"Uchi, R. et al. Integrated multiregional analysis proposing a new model of colorectal cancer evolution. PLoS Genet. 12, e1005778 (2016).","journal-title":"PLoS Genet."},{"key":"934_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-018-0024-3","volume":"556","author":"SF Roerink","year":"2018","unstructured":"Roerink, S. F. et al. Intra-tumour diversification in colorectal cancer at the single-cell level. Nature 556, 457\u2013462 (2018).","journal-title":"Nature"},{"key":"934_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan, N. & Swanton, C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168, 613\u2013628 (2017).","journal-title":"Cell"},{"key":"934_CR8","doi-asserted-by":"publisher","first-page":"5936","DOI":"10.1158\/1078-0432.CCR-17-0821","volume":"23","author":"M Gausachs","year":"2017","unstructured":"Gausachs, M. et al. Mutational heterogeneity in APC and KRAS arises at the crypt level and leads to polyclonality in early colorectal tumorigenesis. Clin. Cancer Res. 23, 5936\u20135947 (2017).","journal-title":"Clin. Cancer Res."},{"key":"934_CR9","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1053\/j.gastro.2010.01.033","volume":"138","author":"C Thirlwell","year":"2010","unstructured":"Thirlwell, C. et al. Clonality assessment and clonal ordering of individual neoplastic crypts shows polyclonality of colorectal adenomas. Gastroenterology 138, 1441\u20131454 (2010). 1454.e1-7.","journal-title":"Gastroenterology"},{"issue":"uppl. 6","key":"934_CR10","doi-asserted-by":"crossref","first-page":"vi64","DOI":"10.1093\/annonc\/mdt354","volume":"24","author":"R Labianca","year":"2013","unstructured":"Labianca, R. et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 24(Suppl. 6), vi64\u2013vi72 (2013).","journal-title":"Ann. Oncol."},{"key":"934_CR11","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/gutjnl-2011-300774","volume":"61","author":"JH Scholefield","year":"2012","unstructured":"Scholefield, J. H., Moss, S. M., Mangham, C. M., Whynes, D. K. & Hardcastle, J. D. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut 61, 1036\u20131040 (2012).","journal-title":"Gut"},{"key":"934_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1258\/jms.2011.011032","volume":"18","author":"TJ Lee","year":"2011","unstructured":"Lee, T. J. et al. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme. J. Med. Screen. 18, 82\u201386 (2011).","journal-title":"J. Med. Screen."},{"key":"934_CR13","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1136\/gutjnl-2011-300843","volume":"61","author":"RF Logan","year":"2012","unstructured":"Logan, R. F. et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 61, 1439\u20131446 (2012).","journal-title":"Gut"},{"key":"934_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1258\/096914107782066220","volume":"14","author":"JA Burch","year":"2007","unstructured":"Burch, J. A. et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J. Med. Screen. 14, 132\u2013137 (2007).","journal-title":"J. Med. Screen."},{"key":"934_CR15","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1002\/ijc.25574","volume":"128","author":"Z Levi","year":"2011","unstructured":"Levi, Z. et al. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study. Int. J. Cancer 128, 2415\u20132424 (2011).","journal-title":"Int. J. Cancer"},{"key":"934_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/ajg.2013.424","volume":"109","author":"H Brenner","year":"2014","unstructured":"Brenner, H., Hoffmeister, M., Birkner, B. & Stock, C. Diagnostic performance of guaiac-based fecal occult blood test in routine screening: state-wide analysis from Bavaria, Germany. Am. J. Gastroenterol. 109, 427\u2013435 (2014).","journal-title":"Am. J. Gastroenterol."},{"key":"934_CR17","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/ije\/dyr008","volume":"40","author":"C von Wagner","year":"2011","unstructured":"von Wagner, C. et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int. J. Epidemiol. 40, 712\u2013718 (2011).","journal-title":"Int. J. Epidemiol."},{"key":"934_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/gut.2009.177089","volume":"59","author":"L Hol","year":"2010","unstructured":"Hol, L. et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 59, 62\u201368 (2010).","journal-title":"Gut"},{"key":"934_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/2150131913487561","volume":"4","author":"JM Daly","year":"2013","unstructured":"Daly, J. M., Bay, C. P. & Levy, B. T. Evaluation of fecal immunochemical tests for colorectal cancer screening. J. Prim. Care Community Health 4, 245\u2013250 (2013).","journal-title":"J. Prim. Care Community Health"},{"key":"934_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","volume":"10","author":"E Crowley","year":"2013","unstructured":"Crowley, E., Di Nicolantonio, F., Loupakis, F. & Bardelli, A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat. Rev. Clin. Oncol. 10, 472\u2013484 (2013).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"934_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"Wan, J. C. M. et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat. Rev. Cancer 17, 223\u2013238 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"934_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/gutjnl-2014-308859","volume":"65","author":"T Reinert","year":"2016","unstructured":"Reinert, T. et al. Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery. Gut 65, 625\u2013634 (2016).","journal-title":"Gut"},{"key":"934_CR23","doi-asserted-by":"publisher","first-page":"346ra392","DOI":"10.1126\/scitranslmed.aaf6219","volume":"8","author":"J Tie","year":"2016","unstructured":"Tie, J. et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci. Transl. Med. 8, 346ra392 (2016).","journal-title":"Sci. Transl. Med."},{"key":"934_CR24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.cell.2017.01.030","volume":"168","author":"AM Aravanis","year":"2017","unstructured":"Aravanis, A. M., Lee, M. & Klausner, R. D. Next-generation sequencing of circulating tumor DNA for early cancer detection. Cell 168, 571\u2013574 (2017).","journal-title":"Cell"},{"key":"934_CR25","doi-asserted-by":"publisher","first-page":"224ra224","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda, C. et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl. Med. 6, 224ra224 (2014).","journal-title":"Sci. Transl. Med."},{"key":"934_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/bjc.2011.230","volume":"105","author":"R Mead","year":"2011","unstructured":"Mead, R., Duku, M., Bhandari, P. & Cree, I. A. Circulating tumour markers can define patients with normal colons, benign polyps, and cancers. Br. J. Cancer 105, 239\u2013245 (2011).","journal-title":"Br. J. Cancer"},{"key":"934_CR27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.21873\/anticanres.11360","volume":"37","author":"M Galanopoulos","year":"2017","unstructured":"Galanopoulos, M. et al. Comparative study of mutations in single nucleotide polymorphism loci of KRAS and BRAF genes in patients who underwent screening colonoscopy, with and without premalignant intestinal polyps. Anticancer Res. 37, 651\u2013657 (2017).","journal-title":"Anticancer Res."},{"key":"934_CR28","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/jnci\/92.11.918","volume":"92","author":"MS Kopreski","year":"2000","unstructured":"Kopreski, M. S. et al. Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA. J. Natl. Cancer Inst. 92, 918\u2013923 (2000).","journal-title":"J. Natl. Cancer Inst."},{"key":"934_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/030089161410000201","volume":"100","author":"F Perrone","year":"2014","unstructured":"Perrone, F. et al. Circulating free DNA in a screening program for early colorectal cancer detection. Tumori 100, 115\u2013121 (2014).","journal-title":"Tumori"},{"key":"934_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9760","volume":"6","author":"M Murtaza","year":"2015","unstructured":"Murtaza, M. et al. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat. Commun. 6, 8760 (2015).","journal-title":"Nat. Commun."},{"key":"934_CR31","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature22364","volume":"545","author":"C Abbosh","year":"2017","unstructured":"Abbosh, C. et al. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545, 446\u2013451 (2017).","journal-title":"Nature"},{"key":"934_CR32","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/annonc\/mdw037","volume":"27","author":"M Jamal-Hanjani","year":"2016","unstructured":"Jamal-Hanjani, M. et al. Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer. Ann. Oncol. 27, 862\u2013867 (2016).","journal-title":"Ann. Oncol."},{"key":"934_CR33","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"Cancer Genome Atlas Network.","year":"2012","unstructured":"Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330\u2013337 (2012).","journal-title":"Nature"},{"key":"934_CR34","first-page":"9","volume":"7","author":"D Barras","year":"2015","unstructured":"Barras, D. BRAF mutation in colorectal cancer: an update. Biomark. Cancer 7, 9\u201312 (2015).","journal-title":"Biomark. Cancer"},{"key":"934_CR35","doi-asserted-by":"publisher","first-page":"S680","DOI":"10.1245\/s10434-014-3804-5","volume":"21","author":"JK Lin","year":"2014","unstructured":"Lin, J. K. et al. Clinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumors. Ann. Surg. Oncol. 21, S680\u2013S686 (2014).","journal-title":"Ann. Surg. Oncol."},{"issue":"Suppl. 4","key":"934_CR36","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00384-011-1238-0","volume":"26","author":"MP Macedo","year":"2011","unstructured":"Macedo, M. P. et al. Multiple mutations in the Kras gene in colorectal cancer: review of the literature with two case reports. Int. J. Colorectal Dis. 26(Suppl. 4), 1241\u20131248 (2011).","journal-title":"Int. J. Colorectal Dis."},{"key":"934_CR37","doi-asserted-by":"publisher","first-page":"11906","DOI":"10.18632\/oncotarget.14439","volume":"8","author":"Y Nagai","year":"2017","unstructured":"Nagai, Y. et al. LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer. Oncotarget 8, 11906\u201311916 (2017).","journal-title":"Oncotarget"},{"key":"934_CR38","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nature07602","volume":"457","author":"N Barker","year":"2009","unstructured":"Barker, N. et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608\u2013611 (2009).","journal-title":"Nature"},{"key":"934_CR39","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nature06196","volume":"449","author":"N Barker","year":"2007","unstructured":"Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003\u20131007 (2007).","journal-title":"Nature"},{"key":"934_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/science.278.5335.120","volume":"278","author":"H Shibata","year":"1997","unstructured":"Shibata, H. et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278, 120\u2013123 (1997).","journal-title":"Science"},{"key":"934_CR41","doi-asserted-by":"crossref","unstructured":"Mouse Genome Sequencing Consortium, et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520\u2013562 (2002).","DOI":"10.1038\/nature01262"},{"key":"934_CR42","doi-asserted-by":"publisher","first-page":"e1000023","DOI":"10.1371\/journal.pgen.1000023","volume":"4","author":"AC Liu","year":"2008","unstructured":"Liu, A. C. et al. Redundant function of REV-ERBalpha and beta and non-essential role for Bmal1 cycling in transcriptional regulation of intracellular circadian rhythms. PLoS Genet. 4, e1000023 (2008).","journal-title":"PLoS Genet."},{"key":"934_CR43","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen, J. D. et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359, 926\u2013930 (2018).","journal-title":"Science"},{"key":"934_CR44","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nmeth898","volume":"3","author":"F Diehl","year":"2006","unstructured":"Diehl, F. et al. BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions. Nat. Methods 3, 551\u2013559 (2006).","journal-title":"Nat. Methods"},{"key":"934_CR45","doi-asserted-by":"publisher","first-page":"8817","DOI":"10.1073\/pnas.1133470100","volume":"100","author":"D Dressman","year":"2003","unstructured":"Dressman, D., Yan, H., Traverso, G., Kinzler, K. W. & Vogelstein, B. Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc. Natl. Acad. Sci. USA 100, 8817\u20138822 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"934_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nmeth850","volume":"3","author":"M Li","year":"2006","unstructured":"Li, M., Diehl, F., Dressman, D., Vogelstein, B. & Kinzler, K. W. BEAMing up for detection and quantification of rare sequence variants. Nat. Methods 3, 95\u201397 (2006).","journal-title":"Nat. Methods"},{"key":"934_CR47","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1038\/onc.2017.281","volume":"36","author":"SH Lee","year":"2017","unstructured":"Lee, S. H. et al. CUT-PCR: CRISPR-mediated, ultrasensitive detection of target DNA using PCR. Oncogene 36, 6823\u20136829 (2017).","journal-title":"Oncogene"},{"key":"934_CR48","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nm.3519","volume":"20","author":"AM Newman","year":"2014","unstructured":"Newman, A. M. et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat. Med. 20, 548\u2013554 (2014).","journal-title":"Nat. Med."},{"key":"934_CR49","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nm0715-827b","volume":"21","author":"G Siravegna","year":"2015","unstructured":"Siravegna, G. et al. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat. Med. 21, 827 (2015).","journal-title":"Nat. Med."},{"key":"934_CR50","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3332\/ecancer.2015.601","volume":"9","author":"K Brown","year":"2015","unstructured":"Brown, K. & Rufini, A. New concepts and challenges in the clinical translation of cancer preventive therapies: the role of pharmacodynamic biomarkers. Ecancermedicalscience 9, 601 (2015).","journal-title":"Ecancermedicalscience"},{"key":"934_CR51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/gutjnl-2017-315333","volume":"67","author":"M Lawler","year":"2018","unstructured":"Lawler, M. et al. Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer. Gut 67, 179\u2013193 (2018).","journal-title":"Gut"},{"key":"934_CR52","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1101\/gr.123497.111","volume":"22","author":"JA Shaw","year":"2012","unstructured":"Shaw, J. A. et al. Genomic analysis of circulating cell-free DNA infers breast cancer dormancy. Genome Res. 22, 220\u2013231 (2012).","journal-title":"Genome Res."},{"key":"934_CR53","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.15252\/emmm.201404913","volume":"7","author":"E Olsson","year":"2015","unstructured":"Olsson, E. et al. Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease. EMBO Mol. Med. 7, 1034\u20131047 (2015).","journal-title":"EMBO Mol. Med."},{"key":"934_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.440","volume":"8","author":"R Hamam","year":"2017","unstructured":"Hamam, R. et al. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers. Cell Death Dis. 8, e3045 (2017).","journal-title":"Cell Death Dis."},{"key":"934_CR55","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/emmm.201100154","volume":"3","author":"F Bianchi","year":"2011","unstructured":"Bianchi, F. et al. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol. Med. 3, 495\u2013503 (2011).","journal-title":"EMBO Mol. Med."},{"key":"934_CR56","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589\u2013595 (2010).","journal-title":"Bioinformatics"},{"key":"934_CR57","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979\u2013993 (2012).","journal-title":"Cell"},{"key":"934_CR58","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","volume":"25","author":"K Ye","year":"2009","unstructured":"Ye, K., Schulz, M. H., Long, Q., Apweiler, R. & Ning, Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865\u20132871 (2009).","journal-title":"Bioinformatics"},{"key":"934_CR59","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/nar\/gnh055","volume":"32","author":"J Cheng","year":"2004","unstructured":"Cheng, J., Zhang, Y. & Li, Q. Real-time PCR genotyping using displacing probes. Nucleic Acids Res. 32, e61 (2004).","journal-title":"Nucleic Acids Res."},{"key":"934_CR60","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0003-2697(03)00081-2","volume":"315","author":"JA Walker","year":"2003","unstructured":"Walker, J. A. et al. Human DNA quantitation using Alu element-based polymerase chain reaction. Anal. Biochem. 315, 122\u2013128 (2003).","journal-title":"Anal. Biochem."},{"key":"934_CR61","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/sj.bjc.6604925","volume":"100","author":"M Beau-Faller","year":"2009","unstructured":"Beau-Faller, M. et al. Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping. Br. J. Cancer 100, 985\u2013992 (2009).","journal-title":"Br. J. Cancer"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0934-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:09:08Z","timestamp":1671520148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0934-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,30]]},"references-count":61,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0934-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,30]]},"assertion":[{"value":"19 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"894"}}